Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Silence Therapeutics (SLN) EPS (Basic): 2020-2025

Historic EPS (Basic) for Silence Therapeutics (SLN) over the last 5 years, with Sep 2025 value amounting to -$0.15.

  • Silence Therapeutics' EPS (Basic) rose 40.00% to -$0.15 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.45, marking a year-over-year increase of 21.07%. This contributed to the annual value of -$0.33 for FY2024, which is 32.65% up from last year.
  • According to the latest figures from Q3 2025, Silence Therapeutics' EPS (Basic) is -$0.15, which was up 21.05% from -$0.19 recorded in Q2 2025.
  • In the past 5 years, Silence Therapeutics' EPS (Basic) ranged from a high of $0.09 in Q4 2024 and a low of -$0.25 during Q3 2024.
  • In the last 3 years, Silence Therapeutics' EPS (Basic) had a median value of -$0.14 in 2023 and averaged -$0.13.
  • In the last 5 years, Silence Therapeutics' EPS (Basic) skyrocketed by 156.21% in 2024 and then slumped by 900.00% in 2025.
  • Over the past 5 years, Silence Therapeutics' EPS (Basic) (Quarterly) stood at -$0.17 in 2021, then increased by 2.75% to -$0.16 in 2022, then grew by 2.33% to -$0.16 in 2023, then soared by 156.21% to $0.09 in 2024, then skyrocketed by 40.00% to -$0.15 in 2025.
  • Its last three reported values are -$0.15 in Q3 2025, -$0.19 for Q2 2025, and -$0.20 during Q1 2025.